Viking Therapeutics Inc (VKTX)

04:36 AM

Viking Therapeutics Inc expected to post a loss of $1.25 a shareEarnings Preview - TradingView

04:36 AM

09:03 AM

Insiders At Viking Therapeutics Sold US$15m In Stock, Alluding To Potential Weakness - Moomoo

09:03 AM

03:27 AM

VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout? - Stocktwits

03:27 AM

Jul 26, 2026

Viking Therapeutics (NASDAQ:VKTX) Stock in Focus Ahead of Cash-Burn Scrutiny, Earnings Set for July 29 - TechStock²

Jul 26, 2026

Jul 26, 2026

VKTX Stock Rises After-Hours: CNBC Flags Viking As Likely Buyout Target This Year As Big Pharma Hunts Next GLP-1 Winner - Stocktwits

Jul 26, 2026

Jul 25, 2026

Viking Therapeutics, Inc. Revenue Breakdown – DUS:1VT - TradingView

Jul 25, 2026

Jul 25, 2026

Viking Therapeutics Inc (VKTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 25, 2026

Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026

Jul 25, 2026

Viking Therapeutics Inc (VKTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 25, 2026

Jul 25, 2026

Viking Therapeutics Inc (VKTX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 25, 2026

Jul 25, 2026

Viking Therapeutics Inc (VKTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 25, 2026

Jul 25, 2026

VKTX Stock Draws Fresh Attention Ahead Of Earnings: Wall Street Sees Over 170% Upside As GLP-1 Race Burns Hot - Stocktwits

Jul 25, 2026

Jul 24, 2026

Viking Therapeutics Inc (VKTX) Institutional Confidence - TradingKey

Jul 24, 2026

Jul 24, 2026

VKTX|Viking Therapeutics Inc|Price:34.770|Chg%:-0.620 - TradingKey

Jul 24, 2026

Jul 24, 2026

VKTX Stock Clocks Best Day In Nearly 3 Months On Obesity Pipeline Optimism, Buyout Speculation - Stocktwits

Jul 24, 2026

Jul 24, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 24, 2026

Jul 24, 2026

Viking Therapeutics Inc (VKTX) Fundamental & Financial Data - Stocktwits

Jul 24, 2026

Jul 24, 2026

VKTX: Viking Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Jul 24, 2026

Jul 24, 2026

Viking Therapeutics (VKTX.US) will release its earnings report after market close on July 29. - 富途牛牛

Jul 24, 2026

Jul 24, 2026

Viking Therapeutics Inc (VKTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 24, 2026

Jul 23, 2026

Viking Therapeutics (VKTX) Stock Could Be Overvalued On Fresh Diabetes Therapy News - Yahoo Finance

Jul 23, 2026

Jul 23, 2026

Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market - Yahoo! Finance Canada

Jul 23, 2026

Jul 23, 2026

Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults - AOL.com

Jul 23, 2026

Jul 23, 2026

Viking Therapeutics adds Dorothy Gemmell to board of directors By Investing.com - Investing.com South Africa

Jul 23, 2026

Jul 23, 2026

Viking Therapeutics adds Dorothy Gemmell to board of directors - Investing.com

Jul 23, 2026

Jul 23, 2026

Press Release: Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors - Moomoo

Jul 23, 2026

Jul 23, 2026

Viking Therapeutics (VKTX) Appoints Dorothy Gemmell To Board As Commercial Focus Grows - Sahm

Jul 23, 2026

Jul 23, 2026

Viking Therapeutics to report Q2 2026 results on July 29 - scanx.trade

Jul 23, 2026

Jul 22, 2026

Viking Therapeutics to Report Financial Results for Second Quart - GuruFocus

Jul 22, 2026

Jul 22, 2026

Viking Therapeutics’ Q2 results arrive after markets close - Stock Titan

Jul 22, 2026

Jul 22, 2026

Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026 - Sahm

Jul 22, 2026

Jul 22, 2026

A New GLP-1 Challenger? Early Data Shows Viking's New Obesity Drug Tops Novo Rival - Stocktwits

Jul 22, 2026

Jul 22, 2026

(VKTX) Risk Channels and Responsive Allocation - Stock Traders Daily

Jul 22, 2026

Jul 21, 2026

Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to C - GuruFocus

Jul 21, 2026

Jul 21, 2026

Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm - Morningstar

Jul 21, 2026

Jul 21, 2026

Viking Therapeutics (VKTX) Stock Analysis: Biotechnology’s Hidden Gem with a 154% Potential Upside - DirectorsTalk Interviews

Jul 21, 2026

Jul 21, 2026

Viking Therapeutics Moves Closer To Challenging Ozempic With Phase 3 Trial Progress - Stocktwits

Jul 21, 2026

Jul 20, 2026

VKTX Stock Outpaces LLY, ALT Ahead Of Earnings – Retail Eyes Breakout Ahead - Stocktwits

Jul 20, 2026

Jul 18, 2026

Investigation into Viking Therapeutics Officers for Fiduciary Breach - Intellectia AI

Jul 18, 2026

Jul 18, 2026

Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1 - The Motley Fool

Jul 18, 2026

Jul 18, 2026

VKTX Eyes Worst Week Since November As Trial Data Looms — Wall Street Still Sees 200% Upside - Stocktwits

Jul 18, 2026

Jul 18, 2026

Viking Therapeutics (NASDAQ:VKTX) stock maintains Phase 3 outlook despite 4.6% fall over the week - TechStock²

Jul 18, 2026

Jul 18, 2026

Should You Buy Viking Therapeutics Stock on the Dip? Wall Street Is Screaming "Yes." - The Motley Fool

Jul 18, 2026

Jul 18, 2026

Should You Buy Viking Therapeutics Stock on the Dip? Wall Street Is Screaming "Yes." - The Motley Fool

Jul 18, 2026

Jul 18, 2026

VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline - Stocktwits

Jul 18, 2026

Jul 17, 2026

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note - Yahoo Finance

Jul 17, 2026

Jul 17, 2026

Viking Therapeutics (VKTX) Could Be 61% Undervalued As It Starts VK3019 Trial - simplywall.st

Jul 17, 2026

Jul 17, 2026

Viking Therapeutics to Report Q2 Earnings: What's in Store for the Stock? - The Globe and Mail

Jul 17, 2026